A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation

Satoru Oka,Yoko Obata,Kenta Torigoe,Miki Torigoe,Shinichi Abe,Kumiko Muta,Yuki Ota,Mineaki Kitamura,Satoko Kawasaki,Misaki Hirose,Tadashi Uramatsu,Hiroshi Yamashita,Hideyuki Arai,Hiroshi Mukae,Tomoya Nishino

A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation

2017

Satoru Oka
Yoko Obata
Kenta Torigoe
Miki Torigoe
Shinichi Abe
Kumiko Muta
Yuki Ota
Mineaki Kitamura
Satoko Kawasaki
Misaki Hirose
Tadashi Uramatsu
Hiroshi Yamashita
Hideyuki Arai
Hiroshi Mukae
Tomoya Nishino

Background and Objective We compared the hemoglobin-maintaining effects between continuous erythropoietin receptor activator (CERA) and darbepoetin-α (DA) in patients with chronic kidney disease (CKD) during the 3 months before dialysis initiation.

Keywords:

Continuous erythropoietin receptor activator
Dialysis
Diabetes mellitus
Pharmacology
Hemoglobin
Kidney disease
Medicine
Intensive care medicine
Urology
Darbepoetin alfa
Pharmacotherapy
Erythropoietin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations